Join BookitisSave favorites, build lists, and follow creators.

John R. Vane

John R. Vane

JR
20 featured booksJohn R. Vane

British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors.

OL342185A

Overview

Catalog identity and bibliographic footprint for this author.

20 representative editions

Author pages in Bookitis are intended to show only works actually attributed to the author and a representative edition for each of those works.

Catalog identity

How this author appears inside the active Bookitis catalog.

  • Display name

    John R. Vane

  • Personal name

    John R. Vane

  • Source identifier

    OL342185A

Featured books

Representative editions for works actually authored by this person.

Works in catalog

Quick navigation into the work-level grouping pages behind the featured books.

  • Selective COX-2 inhibitors

    Representative edition published 2012

    Open Work
  • Inflammation

    Representative edition published 2011

    Open Work
  • Clinician's Manual on COX-2 Inhibition

    Representative edition published 1999

    Open Work
  • Eicosanoids, aspirin, and asthma

    Representative edition published 1998

    Open Work
  • Clinical Significance And Potential Of Selective Cox-2 Inhibitors

    Representative edition published 1998

    Open Work
  • New targets in inflammation

    Representative edition published 1996

    Open Work
  • Improved non-steroid anti-flammatory drugs COX-2 enzyme inhibitors

    Representative edition published 1996

    Open Work
  • Therapeutic Application of Prostaglandins

    Representative edition published 1993

    Open Work
  • Aspirin and other salicylates

    Representative edition published 1992

    Open Work
  • Prostacyclin

    Representative edition published 1979

    Open Work
  • Anti-Inflammatory Drugs

    Representative edition published 1979

    Open Work
  • Inflammation

    Representative edition published 1978

    Open Work
  • Metabolic functions of the lung

    Representative edition published 1977

    Open Work
  • Prostaglandin synthetase inhibitors

    Representative edition published 1974

    Open Work
  • Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research

    Representative edition published 2013

    Open Work
  • Improved Non-Steroid Anti-Inflammatory Drugs

    Representative edition published 2012

    Open Work
  • Therapeutic Roles Of Selective Cox-2 Inhibitors

    Representative edition published 2001

    Open Work
  • Endothelial Cell in Health and Disease

    Representative edition published 1995

    Open Work
  • Asthma

    Representative edition published 1989

    Open Work
  • Prostacyclin inhealth and disease

    Representative edition published 1982

    Open Work